[{"AccountsPayableCurrent_0_Q2_USD":49071000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q2_USD":-2500000.0,"ProvisionForLoanLeaseAndOtherLosses_2_Q2_USD":1057000.0,"TaxAdjustmentsSettlementsAndUnusualProvisions_2_Q2_USD":4100000.0,"TaxAdjustmentsSettlementsAndUnusualProvisions_1_Q2_USD":100000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":613000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":397000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":208985000.0,"IncreaseDecreaseInPrepaidTaxes_2_Q2_USD":635000.0,"EarningsPerShareDiluted_2_Q2_USD":1.15,"EarningsPerShareDiluted_1_Q2_USD":0.94,"RepaymentsOfLongTermDebt_2_Q2_USD":8750000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1259000.0,"LongTermDebtCurrent_0_Q2_USD":167001000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":4306000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-2500000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":62936000.0,"ProceedsFromDivestitureOfBusinesses_2_Q2_USD":44978000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":6663000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":5234000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_2_Q2_USD":383000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_1_Q2_USD":264000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":65291000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":53335000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":742000.0,"ProvisionForDoubtfulAccounts_1_Q2_USD":483000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":568748000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":50557000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":50696000.0,"OtherAssetsNoncurrent_0_Q2_USD":71380000.0,"LongTermDebtNoncurrent_0_Q2_USD":297016000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":54956000.0,"Goodwill_0_Q2_USD":214594000.0,"OtherLiabilitiesCurrent_0_Q2_USD":93270000.0,"OtherAssetImpairmentCharges_1_Q2_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":209486000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":405063000.0,"RestructuringReserveAcceleratedDepreciation_2_Q2_USD":2186000.0,"RestructuringReserveAcceleratedDepreciation_1_Q2_USD":644000.0,"RestructuringReserve_0_Q2_USD":1680000.0,"RestructuringCharges_1_Q2_USD":-73000.0,"RestructuringCharges_2_Q2_USD":992000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2_Q2_USD":-2906000.0,"ProceedsFromRepaymentsOfShortTermDebt_2_Q2_USD":90000000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":16606000.0,"PaymentsForRepurchaseOfEquity_2_Q2_USD":0.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":362000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2_Q2_USD":3757000.0,"NumberOfOperatingSegments_2_Q2_segment":3.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":29226000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":13890000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":-1902000.0,"EmployeeStockOwnershipPlanESOPCashContributionsToESOP_2_Q2_USD":2144000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":3019000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":13700000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":4800000.0,"ContractWithCustomerLiability_0_Q2_USD":17500000.0,"ContractWithCustomerAssetNet_0_Q2_USD":6700000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":141858000.0,"BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_1_Q2_USD":200000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5952000.0,"RevenueRemainingPerformanceObligation_0_Q2_USD":19100000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-20000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":104187000.0,"OtherAssetImpairmentCharges_2_Q2_USD":1028000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":82349000.0,"RevenueRemainingPerformanceObligationPercentage_0_Q2_pure":0.61,"GainLossOnDispositionOfAssets1_2_Q2_USD":31498000.0,"EarningsPerShareBasic_2_Q2_USD":1.16,"StockholdersEquity_0_Q2_USD":667923000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":137140000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":240405000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_2_Q2_USD":902000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":34353000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":16035000.0,"NetIncomeLoss_2_Q2_USD":58628000.0,"NetIncomeLoss_1_Q2_USD":48101000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":40967000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":13239000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":84633000.0,"LiabilitiesCurrent_0_Q2_USD":338568000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1418174000.0,"InventoryNet_0_Q2_USD":305224000.0,"AdjustmentForAmortization_1_Q2_USD":8136000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-22391000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":6855000.0,"GrossProfit_2_Q2_USD":195774000.0,"GrossProfit_1_Q2_USD":105744000.0,"CommonStockValue_0_Q2_USD":507000.0,"CommonStockSharesOutstanding_0_Q2_shares":50703343.0,"CommonStockSharesIssued_0_Q2_shares":50703343.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":279169000.0,"AssetsCurrent_0_Q2_USD":760279000.0,"Assets_0_Q2_USD":1418174000.0,"AssetImpairmentCharges_2_Q2_USD":1028000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":800000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":600000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-38472000.0,"AccountsReceivableNetCurrent_0_Q2_USD":141533000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":4308000.0,"GainLossOnDispositionOfAssets1_1_Q2_USD":31498000.0,"AdjustmentForAmortization_2_Q2_USD":16399000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"EarningsPerShareBasic_1_Q2_USD":0.95,"DeferredOtherTaxExpenseBenefit_2_Q2_USD":-3031000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":209289000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":103742000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-7561000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-3826000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":127210000.0,"IncreaseDecreaseInInventories_2_Q2_USD":38189000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-24770000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.068,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.125,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":10480000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":2699000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":51170000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":2699000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":51093000.0,"ShareBasedCompensation_2_Q2_USD":12119000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":141234000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":71697000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":14513000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":6763000.0,"OperatingIncomeLoss_2_Q2_USD":70497000.0,"OperatingIncomeLoss_1_Q2_USD":58782000.0,"OperatingExpenses_2_Q2_USD":125277000.0,"OperatingExpenses_1_Q2_USD":46962000.0,"InterestPaidNet_2_Q2_USD":4637000.0,"IncomeTaxesPaidNet_2_Q2_USD":4099000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":299450000.0,"DepreciationAndAmortization_2_Q2_USD":41603000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":67000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q2_USD":0.0,"Ticker":"HAE","CIK":"313143","name":"HAEMONETICS CORP","OfficialName":"Haemonetics Corporation Common Stock","form":"10-Q","period":"20200930","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2918472075.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NYSE","SP500":"nan","filed":"20201104"}]